nip

Rivals may nip at Ranbaxy’s US spoils BANGALORE: Several copycat drugmakers in India are looking to chip away at market shares of Ranbaxy Laboratories Ltd, currently under probe by US drug regulators and government departments, before a decision comes on lifting the ban on the exports of 30...